Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

References for PMC Articles for PubMed (Select 18586690)

1.

Dose translation from animal to human studies revisited.

Reagan-Shaw S, Nihal M, Ahmad N.

FASEB J. 2008 Mar;22(3):659-61. Epub 2007 Oct 17.

2.

Resveratrol suppresses prostate cancer progression in transgenic mice.

Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA.

Carcinogenesis. 2007 Sep;28(9):1946-53. Epub 2007 Aug 3.

3.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52.

4.

Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.

Benitez DA, Pozo-Guisado E, Clementi M, Castellón E, Fernandez-Salguero PM.

Br J Cancer. 2007 May 21;96(10):1595-604. Epub 2007 May 8.

5.

Cancer statistics, 2007.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ.

CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66.

PMID:
17237035
8.

Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.

Takahashi Y, Lavigne JA, Hursting SD, Chandramouli GV, Perkins SN, Kim YS, Wang TT.

Mol Carcinog. 2006 Dec;45(12):943-56.

PMID:
16865672
9.

Therapeutic potential of resveratrol: the in vivo evidence.

Baur JA, Sinclair DA.

Nat Rev Drug Discov. 2006 Jun;5(6):493-506. Epub 2006 May 26. Review.

PMID:
16732220
11.

Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Shaw RJ, Cantley LC.

Nature. 2006 May 25;441(7092):424-30. Review.

PMID:
16724053
12.

Genistein affects androgen-responsive genes through both androgen- and estrogen-induced signaling pathways.

Takahashi Y, Hursting SD, Perkins SN, Wang TC, Wang TT.

Mol Carcinog. 2006 Jan;45(1):18-25.

PMID:
16299812
13.

Akt-regulated pathways in prostate cancer.

Majumder PK, Sellers WR.

Oncogene. 2005 Nov 14;24(50):7465-74. Review.

PMID:
16288293
14.

Detection of apoptosis in cardiovascular diseases.

Hunter AL, Choy JC, Granville DJ.

Methods Mol Med. 2005;112:277-89. Review.

PMID:
16010024
15.

Resveratrol-induced gene expression profiles in human prostate cancer cells.

Jones SB, DePrimo SE, Whitfield ML, Brooks JD.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):596-604.

16.

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y.

Anticancer Res. 2004 Sep-Oct;24(5A):2783-840. Review.

17.

Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.

Gehm BD, Levenson AS, Liu H, Lee EJ, Amundsen BM, Cushman M, Jordan VC, Jameson JL.

J Steroid Biochem Mol Biol. 2004 Mar;88(3):223-34.

PMID:
15120416
18.
19.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M.

Lancet. 2004 Apr 24;363(9418):1346-53. Review.

PMID:
15110491
20.

Antiproliferative effect of resveratrol in human prostate carcinoma cells.

Kim YA, Rhee SH, Park KY, Choi YH.

J Med Food. 2003 Winter;6(4):273-80.

PMID:
14977434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk